A case of metastatic treatment‐emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy

A case of metastatic treatment‐emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy

Introduction Treatment‐emergent small cell/neuroendocrine prostate cancer occurs predominantly in advanced or metastatic castration‐resistant prostate cancer that arises when prostate adenocarcinoma is transformed after androgen deprivation therapy. The clinical course for the pathogenesis involved...

Full description

Bibliographic Details
Main Authors: Taku Naiki, Aya Naiki‐Ito, Tatsuya Kawai, Hirokazu Komatsu, Ryutaro Nishikawa, Masakazu Gonda, Maria Aoki, Yosuke Sugiyama, Yoshihiko Tasaki, Takahiro Yasui
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:IJU Case Reports
Subjects:
BRCA2 mutation
castration resistant
treatment‐emergent small cell/neuroendocrine prostate cancer
Online Access:https://doi.org/10.1002/iju5.12501

Internet

https://doi.org/10.1002/iju5.12501

Similar Items